Swiss HIV Cohort Study

Leon-Reyes et al., Kostenabschätzung zur Behandlung HIV-infizierter Personen in der Schweiz

Kostenabschätzung zur Behandlung HIV-infizierter Personen in der Schweiz.    Clinical Infectious Diseases Um die aktuellen und zukünftigen Bedürfnisse von HIV-infizierten Personen in der Schweiz abschätzen zu können, sind verlässliche Daten zu den Kosten und der Ressourcennutzung im Gesundheitswesen von entscheidender Bedeutung. Bisherige Studien zu den Kosten, welche bei der Behandlung HIV-infizierter Personen anfallen, waren nicht repräsentativ […]

Kurioka et al., CD161-expressing NK cells

CD161 defines a functionally distinct subset of pro-inflammatory NK cells.    Frontiers Natural killer (NK) cells are the most classical population of innate lymphoid cells, expressing a heterogeneous repertoire of germline-encoded receptors that allows them to distinguish infected or stressed cells from healthy cells. CD161 is a C-type lectin-like receptor expressed on the majority of […]

Laut et al., Variation among HIV key populations

Variation in antiretroviral treatment (ART) coverage and virological suppression among three HIV key populations.   AIDS Laut et al. on behalf of the EuroSIDA study group aimed to assess differences in antiretroviral treatment (ART) coverage and virological suppression across the three HIV transmission categories i) men who have sex with men, ii) injection drug users […]

Rohner et al, Regional NHL risk in HIV-positive adults

Non-Hodgkin lymphoma risk in adults living with HIV across five continents.    AIDS Rohner et al. for the AIDS-defining Cancer Project Working Group of IeDEA and COHERE in EuroCoord aimed to compare non-Hodgkin lymphoma (NHL) incidence rates in adults who started antiretroviral therapy (ART) after 1995 across the Asia-Pacific, South Africa, Europe, Latin, and North […]

Ronit et al., Serum albumin and non-AIDS events

Associations between serum albumin and serious non-AIDS events among people living with HIV.   AIDS Ronit et al. for the D:A:D Study Group aimed to undertake a detailed evaluation of the association between serum albumin (sAlb) and serious non-AIDS events (SNAE) in a large and heterogeneous study population with long follow-up. SNAE was defined as […]

Shepherd et al., Cessation of cigarette smoking and cancer in HIV

Cessation of cigarette smoking and the impact on cancer incidence in HIV-positive persons: The D:A:D Study.     Clinical Infectious Diseases Despite the well characterized harms of smoking in people living with HIV (PLWH), the clinical benefits of smoking cessation on cancer risk have not previously been reported in large epidemiological studies. The aim of […]

Salazar-Vizcaya et al., Influence des thérapies hautement efficaces du virus de l’hépatite C sur le nombre d’infections chez les personnes à risque

Influence des thérapies hautement efficaces du virus de l’hépatite C sur le nombre d’infections chez les personnes à risque.   Open Forum Infectious Diseases L’Organisation mondiale de la santé (OMS) a fixé comme but de réduire de 90% les nouvelles infections par le virus de l’hépatite C (VHC) jusqu’en 2030. Afin d’atteindre ce but, il […]

Salazar-Vizcaya et al., Influenza delle terapie antivirali ad azione diretta per il virus dell’epatite C sul numero di infezioni nelle persone a rischio

Influenza delle terapie antivirali ad azione diretta per il virus dell’epatite C sul numero di infezioni nelle persone a rischio.    Open Forum Infectious Diseases L’organizzazione mondiale della sanità (OMS) ha fissato come obiettivo di ridurre del 90% le nuove infezioni da virus dell’epatite C (HCV) entro il 2030. Per poter raggiungere tale obiettivo, è […]

Salazar-Vizcaya et al., Einfluss der hochwirksamen Hepatitis C Therapien auf die Krankheitslast bedingt durch HCV Infektionen bei Personen mit einem erhöhten Risiko für Hepatitis C

Einfluss der hochwirksamen Hepatitis C Therapien auf die Krankheitslast bedingt durch HCV Infektionen bei Personen mit einem erhöhten Risiko für Hepatitis C.    Open Forum Infectious Diseases Die Weltgesundheitsorganisation (WHO) hat sich zum Ziel gesetzt, Hepatitis C Virus (HCV) Neuinfektionen bis 2030 um 90% zu reduzieren. Um dieses Ziel zu erreichen ist es entscheidend, die […]

Slogrove et al., The epidemiology of adolescents living with perinatally acquired HIV

The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis.   PLoS Medicine Slogrove et al. for the Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration aimed to describe the global epidemiology of adolescents living with perinatally acquired HIV (APH) in terms of geographic and temporal trends […]